Sodium butyrate abolishes lipopolysaccharide-induced depression-like behaviors and hippocampal microglial activation in mice

Cited by (203)

Items 101–200 of 203

1. Probiotics as a Treatment for “Metabolic Depression”? A Rationale for Future Studies
   Oliwia Gawlik-Kotelnicka, Dominik Strzelecki · 2021 · Pharmaceuticals
2. Reviewing the role of gut microbiota in the pathogenesis of depression and exploring new therapeutic options
   Wenjie Han, Na Wang, Mengzhen Han, Meng Ban, Tao Sun, Junnan Xu · 2022 · Frontiers in Neuroscience
3. Microbial metabolites regulate social novelty via CaMKII neurons in the BNST
   Chia-Wei Liou, Sin‐Jhong Cheng, Tzu-Hsuan Yao, Tzu-Ting Lai, Yu-Hsuan Tsai, Che-Wei Chien, Yu‐Lun Kuo, Shih-Hsuan Chou, Cheng‐Chih Hsu, Wei‐Li Wu · 2023 · Brain Behavior and Immunity
4. Deciphering Neuroprotective Effect of Rosmarinus officinalis L. (syn. Salvia rosmarinus Spenn.) through Preclinical and Clinical Studies
   Ibukun Oluwabukola Oresanya, İlkay Erdoğan Orhan · 2024 · Current Drug Targets
5. Add-on probiotics for inflammatory depression – A double-blind randomized placebo-controlled trial
   Gustav Söderberg Veibäck, Jesper Lindahl, Klara Suneson, Johanna Tjernberg, Darya Ståhl, Rikard Landberg, Marie Asp, Amanda Kjellberg, Fabian Falknäs, Klas Sjöberg et al. · 2025 · Brain Behavior and Immunity
6. The Influence of Probiotic Supplementation on Depressive Symptoms, Inflammation, and Oxidative Stress Parameters and Fecal Microbiota in Patients with Depression Depending on Metabolic Syndrome Comorbidity—PRO-DEMET Randomized Study Protocol
   Oliwia Gawlik-Kotelnicka, Anna Skowrońska, Aleksandra Margulska, Karolina H. Czarnecka, Igor Łoniewski, Karolina Skonieczna‐Żydecka, Dominik Strzelecki · 2021 · Journal of Clinical Medicine
7. Nutraceuticals for Gut–Brain Axis Health: A Novel Approach to Combat Malnutrition and Future Personalised Nutraceutical Interventions
   Litai Liu, Wen Qi, Na Zhang, Jinhao Zhang, Shen Liu, Huan Wang, Lianzhou Jiang, Ying B Sun · 2025 · Nutrients
8. Gut microbiota as a novel target for treating anxiety and depression: from mechanisms to multimodal interventions
   Zhang Ruohan, Wang Ruting, Wu Hongxi, Huang Zhenjin, Liang Jiale, Zhang Rongxin, Feng Jiang, Song Yuanbo · 2025 · Frontiers in Microbiology
9. Exome-wide association study of treatment-resistant depression suggests novel treatment targets
   Shrey Shah, Teja Peddada, Christopher Song, Maame Mensah, Heejong Sung, Mani Yavi, Peixiong Yuan, Carlos A. Zarate, Brian J. Mickey, Margit Burmeister et al. · 2023 · Scientific Reports
10. The dietary ligands, omega-3 fatty acid endocannabinoids and short-chain fatty acids prevent cytokine-induced reduction of human hippocampal neurogenesis and alter the expression of genes involved in neuroinflammation and neuroplasticity
    Gargi Mandal, Silvia Alboni, Nadia Cattane, Moira Marizzoni, Samantha Saleri, Nikita Arslanovski, Nicole Mariani, Madeline Kirkpatrick, Annamaria Cattaneo, Carmine Maria Pariante et al. · 2025 · Molecular Psychiatry
11. The role of gut microbiota metabolites in the regeneration and protection of nervous tissue: a narrative review
    Olha Kostiuchenko, Iryna Lushnikova, G. G. Skibo · 2024 · Regenerative medicine reports .
12. Sodium Butyrate ameliorates pain and mood disorders in a mouse model of Parkinson disease
    Carmen Avagliano, Carmen De Caro, Mariarosaria Cuozzo, Roberta Roberti, Emilio Russo, Giovanna La Rana, Roberto Russo · 2025 · Biomedicine & Pharmacotherapy
13. Antidepressant-like effect of triterpenoids extracts from Poria cocos on the CUMS rats by 16S rRNA gene sequencing and LC–MS metabolomics
    Xiaoxia Gao, Yan Feng, Huanhuan Xue, Meidai Meng, Xuemei Qin · 2020 · Journal of Liquid Chromatography & Related Technologies
14. Implications of Gut-Brain axis in the pathogenesis of Psychiatric disorders
    Kurumi Taniguchi, Yuka Ikeda, Nozomi Nagase, Ai Tsuji, Yasuko Kitagishi, Satoru Matsuda · 2021 · AIMS bioengineering
15. Microbiome and motor neuron diseases
    Kaberi Chatterjee, Sugato Banerjee · 2020 · Progress in molecular biology and translational science
16. Assessing the Beneficial Effects of the Immunomodulatory Glycan LNFPIII on Gut Microbiota and Health in a Mouse Model of Gulf War Illness
    Ryan S. Mote, Jessica M. Carpenter, Rachel L. Dockman, Andrew J. Steinberger, Garret Suen, Thomas Norberg, Donald A. Harn, John J. Wagner, Nikolay M. Filipov · 2020 · International Journal of Environmental Research and Public Health
17. Preclinical and clinical evidence of the association of colibactin-producing Escherichia coli with anxiety and depression in colon cancer
    Fabien Rondepierre, Maëva Meynier, Johan Gagnière, Vincent Deneuvy, Anissa Deneuvy, Gwenaëlle Roche, Elodie Baudu, Bruno Pereira, Richard Bonnet, Nicolas Barnich et al. · 2024 · World Journal of Gastroenterology
18. Neutrophils in the Focus: Impact on Neuroimmune Dynamics and the Gut–Brain Axis
    Antea Kršek, Lara Batičić · 2024 · Gastrointestinal Disorders
19. The immunomodulatory effects of ethosuximide and sodium butyrate on experimentally induced fibromyalgia: The interaction between IL-4, synaptophysin, and TGF-β1/NF-κB signaling
    Maaly A. Abd Elmaaboud, Marwa Mahmoud Awad, Rehab Ahmed Ahmed El‐Shaer, Ahmed M. Kabel · 2023 · International Immunopharmacology
20. Investigation of the impact of preconditioning with lipopolysaccharide on inflammation-induced gene expression in the brain and depression-like behavior in male mice
    Minori Koga, Hiroyuki Toda, Manabu Kinoshita, Fumiho Asai, Masanori Nagamine, Kunio Shimizu, Yasushi Kobayashi, Yuji Morimoto, Aihide Yoshino · 2020 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
21. From gut to glee: Is butyrate a promising antidepressant? A systematic review and mechanistic insights
    Vera Korenblik, Natalia Schilder, Ilke G.S. de Lange, Joost G. Daams, Claudi Bockting, Stanley Brul, Max Nieuwdorp, Anja Lok, Anikó Kőrösi · 2025 · Brain Behavior and Immunity
22. Bioinformatics Approach to Identify the Pathogenetic Link of Gut Microbiota-Derived Short-Chain Fatty Acids and Ischemic Stroke
    Liang Ding, Jia‐Ning Wang, Sha Qiu, Zhizhen Ren, Yuantao Li, Pengpeng An · 2024 · Molecular Neurobiology
23. New perspectives on microbiome-dependent gut-brain pathways for the treatment of depression with gastrointestinal symptoms: from bench to bedside
    Menglin Liu, Genhao Fan, Lingkai Meng, Kuo Yang, Huayi Liu · 2024 · Journal of Zhejiang University SCIENCE B
24. A novel set of volatile urinary biomarkers for late-life major depressive and anxiety disorders upon the progression of frailty: a pilot study
    Akiko Fujita, Kazushige Ihara, Hisashi Kawai, Shuichi P. Obuchi, Yutaka Watanabe, Hirohiko Hirano, Yoshinori Fujiwara, Yoichi Takeda, Masashi Tanaka, Keiko Kato · 2022 · Discover Mental Health
25. Cajaninstilbene acid ameliorates depression-like behaviors in mice by suppressing TLR4/NF-κB mediated neuroinflammation and promoting autophagy
    Tao Xue, Yunfeng Zhou, Zhi Wang, Lisha Wang, Tianji Xia, Mingzhu Yan, Qi Chang · 2024 · Behavioural Brain Research
26. The Metabolomic Mind: Microbial Metabolite Programming of Microglia
    Branden G. Verosky, Michael T. Bailey, Tamar Gur · 2025 · NeuroImmunoModulation
27. Therapeutic Potential of Sodium Butyrate in Neurological and Psychiatric Disorders
    Dibachehr Rahmani, Leila Chodari, Mohammad Kakallahpour, Zahra Niknam · 2025 · Molecular Neurobiology
28. Systemic Administration of Porphyromonas Gingivalis Lipopolysaccharide Induces Glial Activation and Depressive-Like Behavior in Rats
    Rahman Mamunur, Sadayuki Hashioka, Ilhamuddin Abdul Azis, ⁠Muhammad Alim Jaya, Sultana Jannatul Ferdoush JERIN, Kaori Kimura‐Kataoka, Junko Fujihara, Ken Inoue, Masatoshi Inagaki, Haruo Takeshita · 2023 · Journal of Integrative Neuroscience
29. Identification of disordered profiles of gut microbiota and functional component in stroke and poststroke epilepsy
    Duncan Wei, Xiaopu Chen, Jing Xu, Yongling Yin, Xiaotang Peng, Shunxian Li, Wenzhen He · 2023 · Brain and Behavior
30. Host gut microbiome and potential therapeutics in Gulf War Illness: A short review
    Saurabh Chatterjee, Dipro Bose, Ratanesh Kumar Seth · 2021 · Life Sciences
31. Integrated gut microbiome and metabolomic analyses elucidate the therapeutic mechanisms of Suanzaoren decoction in insomnia and depression models
    Hongxiong Zhang, Taixiang Gao, Feng Zhao, Nan Wang, Z Li, Xuemei Qin, Ying Liu, Rui Ying Wang · 2024 · Frontiers in Neuroscience
32. Quercetin ameliorates chronic restraint stress- and LPS-induced anxiety-like behaviors by modulating neuroinflammation in the lateral hypothalamus
    Xinxin Wang, GuangDong Weng, Yunpei Gao, Yu Wang, Chengxin Zhang · 2025 · Psychopharmacology
33. Phospholipase C-related catalytically inactive protein regulates lipopolysaccharide-induced hypothalamic inflammation-mediated anorexia in mice.
    Y. Yamawaki, Satomi Shirawachi, Akiko Mizokami, Kanako Nozaki, Hikaru Ito, S. Asano, Kana Oue, H. Aizawa, S. Yamawaki, M. Hirata et al. · 2019 · Neurochemistry International
34. Insights into host-microbe interaction: What can we do for the swine industry?
    Lijuan Fan, Bingnan Liu, Ziyi Han, Wenkai Ren · 2020 · Animal nutrition
35. Immunology and microbiology: how do they affect social cognition and emotion recognition?
    Weronika Barcik, Giulia Chiacchierini, Zisis Bimpisidis, Francesco Papaleo · 2021 · Current Opinion in Immunology
36. Specialized, Pro-Resolving Mediators as Potential Therapeutic Agents for Alleviating Fibromyalgia Symptomatology
    Gregory Livshits, Alexander Kalinkovich · 2021 · Pain Medicine
37. The Muscle‐Gut‐Brain Axis and Psychiatric Illness
    Mary Scriven, Angela McSweeney, Therese O'Carroll, Sabrina Mörkl, Mary Butler · 2023 · Advanced Biology
38. Butyrate suppresses experimental necrotizing enterocolitis–induced brain injury in mice
    Maribel Martinez, Wei Yu, Heather L. Menden, Tianhua Lei, Paula Monaghan‐Nichols, Venkatesh Sampath · 2023 · Frontiers in Pediatrics
39. Recent Advances on Possible Association Between the Periodontal Infection of Porphyromonas gingivalis and Central Nervous System Injury
    Wenlei Yu, Linjie Lu, Xintong Ji, Qiwei Qian, Xiaohan Lin, Huanhuan Wang · 2021 · Journal of Alzheimer s Disease
40. Nutrition and Brain Functions in Health and Disease
    Heba Mohamed Mansour · 2022 · Nutritional neurosciences
41. Maternal high-fat diet alters the neurobehavioral, biochemical and inflammatory parameters of their adult female rat offspring
    Anne Caroline Alves Vieira, Rafael Oliveira Pinheiro, Naís Lira Soares, Maria Luiza Rolim Bezerra, Davi dos Santos Nascimento, Adriano Francisco Alves, Maria Carolina de Paiva Sousa, Maria Letícia da Veiga Dutra, Marcos dos Santos Lima, Nilcimelly Donato et al. · 2023 · Physiology & Behavior
42. Gut Microbiota Metabolites Differentially Release Gliotransmitters from the Cultured Human Astrocytes: A Preliminary Report
    Karbownik, Michał Seweryn, Sokołowska, Paulina, Kowalczyk, Edward · 2023 · International Journal of Molecular Sciences
43. Gut–brain axis and depression: focus on the amino acid and short-chain fatty acid metabolism
    Mengjing Chen, Qiuju Lyu, Lina Huang, Yeliang Lou, Lingfeng Wang · 2025 · Behavioural Pharmacology
44. Consecutive intra-gingival injections of lipopolysaccharide and butyric acid to mice induce abnormal behavior and changes in cytokine concentrations
    Takamitsu Tsukahara, Atsushi Toyoda, Takahiro Kawase, Shinichi Nakamura, Kuniyasu Ochiai · 2020 · Journal of Neuroinflammation
45. Glioblastoma chemoresistance: roles of the mitochondrial melatonergic pathway
    George Anderson · 2020 · Cancer Drug Resistance
46. Circulating Short-Chain Fatty Acid (SCFA) profiles as a biomarker of gut-brain axis dysfunction: A meta-analysis for the SCFA signature in major depression
    Quang Le Do, Ikbal Andrian Malau, Hoan Thi Nguyen, Jiaming Liu, Jane Pei‐Chen Chang, Kuan‐Pin Su · 2026 · Biomedical Journal
47. Rosiglitazone attenuates lipopolysaccharide-induced depressive-like behavior and cognitive deficits in mice
    I.J.V. Stupp, E.B. Fraga-Junior, Diego Luiz Doneda, E.H. Taniguti, Y.S. Ferreira, Beatriz Schmidt Dal Berto, Cláudia Bonadiman de Lima, Carlos Henrique Rocha-Junior, Eliângela de Lima, Fabrício Rios-Santos et al. · 2018 · Journal of Clinical and Molecular Medicine
48. Differences in cognition, short-chain fatty acids and related metabolites in pregnant versus non-pregnant women: a cross-sectional study
    Huijuan Luo, Wengxiang Li, Lulu Wu, Shuming Zhong, Chengrong Du, Yimeng Liu, Yating Xu, Xinyu Huang, Awol Hanan Bahru, Xiaomei Tang et al. · 2022 · BMC Pregnancy and Childbirth
49. Benchmarking post-GWAS analysis tools in major depression: Challenges and implications
    Judith Pérez‐Granado, Janet Piñero, Laura Ines Furlong · 2022 · Frontiers in Genetics
50. The impact of early life stress and immune challenge on behavior and glia cells alteration in late adolescent rats
    Gislaine Z. Réus, Vijayasree Vayalanellore Giridharan, Airam Barbosa de Moura, Laura A. Borba, Maria Eduarda M. Botelho, João Paulo Behenck, Jaqueline S. Generoso, Sudhakar Selvaraj, Gursimrat S. Bhatti, Tatiana Barichello et al. · 2021 · International Journal of Developmental Neuroscience
51. Short-chain fatty acids in mood and schizophrenia spectrum disorders: Evidence in the field and translational perspectives
    Julia Karska, Karolina Skonieczna‐Żydecka, Natalia Jakubiak, Wiktoria Czarnecka, Błażej Misiak · 2025 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
52. Exploring the Link Between the Gut Microbiota and Epigenetic Factors in Anorexia Nervosa
    N. M. Korten, Anna C. Thelen, Clara Voelz, Cordian Beyer, Jochen Seitz, Stefanie Trinh, L. Blischke · 2025 · Brain and Behavior
53. Gut microbiota-derived indole metabolites in depression: mechanisms and therapeutic potential
    Xuli Wang, Ruisi Liu, Jun Liu, Yudong Lin, Mingmei Zhou · 2026 · European Journal of Pharmacology
54. Alterations of short-chain fatty acids in depression and effects of probiotics/prebiotics interventions on levels and clinical symptoms: a systematic review and meta-analysis
    Li J, Haoqi Liu, Min Wang, Kaiqiang Dong, Rongjuan Guo · 2026 · BMC Psychiatry
55. Microglia as a Potential Target for Antidepressant: A Systematic Review on Preclinical studies
    Baiq Risky Wahyu Lisnasari, Chrismawan Ardianto, Junaidi Khotib · 2022 · Research Journal of Pharmacy and Technology
56. Improvement of bowel movements among people with a sedentary lifestyle after prebiotic snack supply – preliminary study
    Ewa Stachowska, Dominika Maciejewska, Joanna Palma, Dominika Jamioł-Milc, Małgorzata Szczuko, Wojciech M. Marlicz, Ewa Wunsch, Karolina Skonieczna‐Żydecka · 2021 · Gastroenterology Review
57. Psychobiotics: A Restorative Intervention for Lifestyle-Induced Deteriorations of Mental Health
    Ananya Tina Banerjee, Priyanka Dey Talukdar, Tiyasa Saha, Anuran Bhattacharya, Kunal Pramanik, Sreeja Chakraborty, Urmi Chatterji · 2024 · Healthy ageing and longevity
58. The Human Microbiome—A Physiologic Perspective
    Xiao Jun Yang, Tijs Louwies, Ruben A. T. Mars, Purna Kashyap · 2024 · Comprehensive physiology
59. High-amylose diet ameliorates LPS-induced cognitive impairment and depression-like phenotype
    Kohei Takura, Ran Wei, Rina Takayanagi, Yasumitsu Sakai, Masahira Hattori, Toshio Ohshima · 2025 · Neuroscience Letters
60. Health risk analysis of micro-and nanoplastic exposure via the microbiota-gut-brain axis
    Xuan Wang, Haoming Yu, Jihong Li, Shengyu Han, Yuhua Chi · 2026 · Frontiers in Immunology
61. Prebiotics attenuate depressive-like behavior, neuroinflammation and synaptic plasticity in Parkinson’s disease by modulating butyrate-producing gut bacteria
    Ingrid Prata Mendonça, Rodrigo Soares da Silva, Igor Henrique Rodrigues de Paiva, Belmira Lara da S. A. Costa, Karla Patrícia de Sousa Barbosa Teixeira, José Roberto Botelho de Souza, Christina Alves Peixoto · 2026 · Inflammopharmacology
62. Harnessing the power of probiotics to enhance neuroplasticity for neurodevelopment and cognitive function in stunting: a comprehensive review
    Khairun Nisa, Rizki Arisandi, Nurhadi Ibrahim, Hardian Hardian · 2023 · International Journal of Neuroscience
63. Metabolomics and the Gut–Brain Axis
    Giorgia Caspani, Michael Harvey, Jonathan Richard Swann · 2024 · Elsevier eBooks
64. Nutritional Psychiatry: The Present State of the Evidence
    Mohamed Ibrahem Baklola · 2024 · Nutritional neurosciences
65. Xiaoyaosan and isoliquiritigenin remodel depression-associated chromatin 3D structure and phase separation of NF-κB p65
    Lili Fan, Xiaowei Mo, Ranran Dai, Jingman Tang, Chunmiao Wan, Shaoyi Fang, Xuan Zhou, Qingyu Ma, Xuxu Zhuang, Yueyue Chen et al. · 2026 · Pharmacological Research
66. Precision prebiotics: Engineering food-derived polysaccharides to target specific SCFA-producing taxa for neuroprotection via the microbiota-gut-brain axis
    Yanmei Yin, Yugang Li, X Zhang, Mengwei Jia, Shu Zhu, Chengcheng Liu · 2026 · Current Research in Food Science
67. The neuroactive potential of the elderly human gut microbiome is associated with mental health status
    Paulina Calderón-Romero, Benjamín Valderrama, Thomaz F. S. Bastiaanssen, Patricia Lillo, Daniela Thumala, Gerard A. Clarke, John F. Cryan, Andrea Slachevsky, Christian Enrique González-Billault, Felipe A. Court · 2026 · PLoS ONE
68. Brain Injury and Neuroinflammation of the Gut-Brain Axis in Subjects with Cerebral Palsy
    Ana Cristina Fernandes Maria Ferreira, Marcelo Freire, Vanessa Lira Siqueira, Carolina de Andrade Ferreira, Maria Teresa Botti Rodrigues Santos · 2021 · IntechOpen eBooks
69. Neurodegenerative Diseases and the Gut Microbiota
    Sílvia Cabré, Kenneth J. O’Riordan, John F. Cryan · 2022 · Progress in inflammation research
70. Gut microbiota metabolites differentially release gliotransmitters from the cultured human astrocytes: a preliminary report
    Michał Seweryn Karbownik, Paulina Sokołowska, Edward Kowalczyk · 2023
71. Beneficial effects and mechanisms of phosvitin on Helicobacter pylori infection-induced gastric injury and abnormal behaviors
    Junlin Ge, Yuting Ye, Lulu Wang, Jiawen Pei, Jie Bai, Xixi Zhang, Ziyuan Liu, Zhijian Dong, Xuebo Liu, Xiang Lin Duan · 2025 · Journal of Future Foods
72. Cytochrome P450 2D6 (CYP2D6) Inhibition by Bergamottin and Diosmetin as a Strategy to Enhance the Pharmacokinetics and Antidepressant Efficacy of Amoxapine
    Sachin Dattram Pawar, Shreyash Santosh Yadav, Sai Sharanya Pulimamidi, Ashok Kumar Datusalia, Pramod Kumar · 2026 · ACS Pharmacology & Translational Science
73. The therapeutic role of microbial metabolites in human health and diseases
    Nivedita Manoharan, Rajeshwari Parasuraman, Dheepthi Jayamurali, Sathya Narayanan Govindarajulu · 2023 · Elsevier eBooks
74. Nurturing the Mind from Within: Exploring the Role of Gut–Microbiota–Brain Axis in Postpartum Depression
    Sriram Naresh, Priya D. Alva, Srinidhi Rai · 2024 · Journal of South Asian Federation of Obstetrics and Gynaecology
75. A relationship between intestinal microbiome and epilepsy: potential treatment options for drug-resistant epilepsy
    A. S. Cherednichenko, P. V. Mozdor, T. K. Oleynikova, P. A. Khatam, F. M. Nastueva, K. O. Kovalenkov, A. S. Serdinova, A. Kh. Osmaeva, A. I. Rovchak, Yu. Yu. Esikova et al. · 2024 · Epilepsy and Paroxysmal Conditions
76. PREBIOTICS FOR ACUTE ISCHEMIC STROKE
    Stephani Nesya Renamastika, Diah Retno Wahyuningrum, VIDA ARIMA PUTRI, Rihadatul Aisy · 2021 · International Journal of Pharmacy and Pharmaceutical Sciences
77. Epigenetic regulation of neuroinflammation in the aged mouse brain
    Stephanie M. Matt · 2018 · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
78. The Effect of Polyunsaturated and Saturated Fatty Acids on Seizure Presence and Severity in a Cohort of Subjects in an Epilepsy Monitoring Unit
    Jana Wells · 2021 · DigitalCommons@UNMC
79. Rifaximin-Mediated Gut Microbiota Regulation Modulates the Polarization of Microglia During CUMS in Rat
    Haonan Li, Yujiao Xiang, Zemeng Zhu, Wei Wang, Zhijun Jiang, Mingyue Zhao, Shuyue Cheng, Fang Pan, Dexiang Liu, Roger Ho et al. · 2021 · Research Square
80. N-butanol fraction of Olax subscorpioidea Oliv. (Olacaceae) attenuates lipopolysaccharide-induced depressive-like symptoms in mice.
    Olusegun Adebayo Adeoluwa, Isaiah Agboola, Elizabeth Toyin Akinluyi, Anthony Taghogho Eduviere, Gladys Onyinye Adeoluwa, Abayomi Mayowa Ajayi, Adegbuyi Oladele Aderibigbe · 2023 · Research Square
81. Gut microbiota characteristics in children with cerebral palsy
    Yinhu Li, Shuai Cheng Li · 2023 · Elsevier eBooks
82. The impact of microbiome alterations on ocular surface diseases
    Kaitlin K. Scholand, Ritu R. Sampige, Adwaita R. Parab, Laura Schaefer, Cintia Sade de Paiva · 2023 · Elsevier eBooks
83. Caracterização do microbioma intestinal em pacientes com diferentes formas de epilepsia e nas encefalites autoimunes mediante análise metagenômica
    Diana Marcela Mejía Granados · 2022
84. Bioinformatics Approach to Identify the Pathogenetic Link of Gut Microbial Metabolites and Stroke
    Liang Ding, Jia‐Ning Wang, Sha Qiu, Zhizhen Ren, Yuantao Li, Pengpeng An · 2024 · Research Square
85. Changes in microglia chromatin accessibility in aged female mice
    Victor A. Ansere, Kyla B. Tooley, Kottapalli Srividya, Walker Hoolehan, Kevin D. Pham, Sarah R. Ocañas, Willard M. Freeman · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
86. Gut–brain communication through microbes
    Miranda Green, Jane Allyson Foster · 2024 · Elsevier eBooks
87. The impact of gut microbiome on neuro-autoimmune demyelinating diseases
    Pouria Abolfazli, Cristina Nkene Apue Nchama, Brandon Peter Lucke-Wold · 2024 · Academia Biology
88. Dairy consumption and the risk of Parkinson's disease
    Randa S. Hasan, Hagar F. Forsan · 2024 · Elsevier eBooks
89. Role of microbiota-gut-brain axis in epilepsy and possible interventions
    Inklisan Patel, Awanish Mishra · 2025 · Elsevier eBooks
90. Epigenetics and pharmacoepigenetics of neuropsychiatric disorders
    Ramón Cacabelos, Natalia Cacabelos, Olaia-Martínez Iglesias, Iván Tellado, Vinogran Naidoo · 2025 · Elsevier eBooks
91. Pharmacoepigenetics of mood disorders
    Fabio Bellia, Patrizia Ballerini, Claudio D’Addario · 2025 · Elsevier eBooks
92. The microbiota-immune interaction in the gut-brain axis
    Redazione · 2025 · PNEI REVIEW
93. Nutritional significance of short-chain fatty acids
    Makbule Gezmen Karadağ, Tuğba Alkan Tuğ, Duygu Ağagündüz, Fatih Özoğul · 2025 · Elsevier eBooks
94. Additional file 3 of Rifaximin-mediated gut microbiota regulation modulates the function of microglia and protects against CUMS-induced depression-like behaviors in adolescent rat
    Li, Haonan, Yujiao Xiang, Zemeng Zhu, Wei Wang, Jiang, Zhijun, Zhao, Mingyue, Cheng, Shuyue, Pan, Fang, Liu, Dexiang, Roger Ho et al. · 2021 · Figshare
95. Additional file 1 of Rifaximin-mediated gut microbiota regulation modulates the function of microglia and protects against CUMS-induced depression-like behaviors in adolescent rat
    Li, Haonan, Yujiao Xiang, Zemeng Zhu, Wei Wang, Jiang, Zhijun, Zhao, Mingyue, Cheng, Shuyue, Pan, Fang, Liu, Dexiang, Roger Ho et al. · 2021 · Figshare
96. Additional file 5 of Rifaximin-mediated gut microbiota regulation modulates the function of microglia and protects against CUMS-induced depression-like behaviors in adolescent rat
    Li, Haonan, Yujiao Xiang, Zemeng Zhu, Wei Wang, Jiang, Zhijun, Zhao, Mingyue, Cheng, Shuyue, Pan, Fang, Liu, Dexiang, Roger Ho et al. · 2021 · Figshare
97. Additional file 2 of Rifaximin-mediated gut microbiota regulation modulates the function of microglia and protects against CUMS-induced depression-like behaviors in adolescent rat
    Li, Haonan, Yujiao Xiang, Zemeng Zhu, Wei Wang, Jiang, Zhijun, Zhao, Mingyue, Cheng, Shuyue, Pan, Fang, Liu, Dexiang, Roger Ho et al. · 2021 · Figshare
98. Additional file 4 of Rifaximin-mediated gut microbiota regulation modulates the function of microglia and protects against CUMS-induced depression-like behaviors in adolescent rat
    Li, Haonan, Yujiao Xiang, Zemeng Zhu, Wei Wang, Jiang, Zhijun, Zhao, Mingyue, Cheng, Shuyue, Pan, Fang, Liu, Dexiang, Roger Ho et al. · 2021 · Figshare
99. Role of intestinal microbiome in depression
    Yuri A. Sergeev, Eduard V. Beyer, Igor A. Bazikov, Tatyana V. Taran · 2025 · Kazan medical journal
100. The microbiota-gut–brain axis in epilepsy: Mechanistic insights and emerging probiotic-based therapeutics
     Tushar Matta, Mahendra Bishnoi, Kanwaljit Chopra, Kanthi Kiran Kondepudi · 2026 · International review of neurobiology